KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Current Assets (2016 - 2025)

Historic Current Assets for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $2.9 billion.

  • Bio-Rad Laboratories' Current Assets fell 409.53% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year decrease of 409.53%. This contributed to the annual value of $2.9 billion for FY2025, which is 409.53% down from last year.
  • According to the latest figures from Q4 2025, Bio-Rad Laboratories' Current Assets is $2.9 billion, which was down 409.53% from $2.8 billion recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Current Assets ranged from a high of $3.3 billion in Q1 2022 and a low of $2.0 billion during Q4 2021
  • Its 5-year average for Current Assets is $2.9 billion, with a median of $3.1 billion in 2023.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 5865.41% in 2022, then crashed by 802.14% in 2025.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Current Assets stood at $2.0 billion in 2021, then soared by 58.65% to $3.2 billion in 2022, then fell by 3.47% to $3.0 billion in 2023, then fell by 0.59% to $3.0 billion in 2024, then decreased by 4.1% to $2.9 billion in 2025.
  • Its Current Assets stands at $2.9 billion for Q4 2025, versus $2.8 billion for Q3 2025 and $2.8 billion for Q2 2025.